Author

David W. Grainger

Observed names: D A Grainger, D GRAINGER, D Grainger, D W Grainger, D. A. Grainger, D. Grainger, D. W. Grainger, D.A Grainger, D.A. Grainger, D.W Grainger, D.W. Grainger, D. W. Grainger, DA Grainger, DAVID GRAINGER, DAVID W. GRAINGER, DW Grainger, David A Grainger, David A. Grainger, David Grainger, David John Grainger, David W Grainger, David W. Grainger2, David William Grainger, Grainger, Grainger, D. W., Grainger, David W., Grainger, David W., advisor, Grainger, David William, Grainger, David, advisor, Grainger, David, committee member
Observed institutions: Creighton University, Portland State University, Brigham and Women's Hospital, University of Wyoming, Rutherford Appleton Laboratory, Dartmouth–Hitchcock Medical Center, Commonwealth Scientific and Industrial Research Organisation, University of Minnesota, Unilever (United Kingdom), Pacific Northwest National Laboratory, Johns Hopkins University, University of Miami, University of Kansas, Emory University, Medical University of South Carolina, Inserm, Oregon Health & Science University, Duke University, University of California, San Francisco, Johannes Gutenberg University Mainz, University of Ferrara, University of Washington, Norwegian University of Science and Technology, University of Utah, University of Cambridge, University of Michigan, Royal Hospital for Women, Yale University, University of Illinois Chicago, University of Oxford, Université Sorbonne Paris Nord, Seattle Reproductive Medicine, Institut Laue-Langevin, Hutzel Women's Hospital, Virginia Spine Institute, Tokyo Women's Medical University, Sequenom (United States), Nitto (United States), University of Utah Health Care, Addenbrooke's Hospital, Hôpital Saint-Luc, Université Laval, Université Paris Diderot, CSIRO Environment, Eli Lilly (Australia), Medicines and Healthcare products Regulatory Agency, The University of Texas Medical Branch at Galveston, Université du Québec à Trois-Rivières, Université de Montréal, Columbia University, University of Pennsylvania, Michigan State University, Colorado State University, Stanford University, Tsinghua University
ORCID: 0000-0003-1506-7286
Observed ORCID: 0000-0003-1506-7286
OpenAlex ID: A5085157952
2015 · Heather Herd Gustafson, Dolly Holt-Casper, et al. · Nano Today · 1,412
2012 · Henk J. Busscher, Henny C. van der Mei, et al. · Science Translational Medicine · 707
2009 · Clinton F. Jones, David W. Grainger · Advanced Drug Delivery Reviews · 554
2016 · Joseph M. Aamodt, David W. Grainger · Biomaterials · 507
2005 · Peng Wu, David W. Grainger · Biomaterials · 490
2012 · Anna Astashkina, Brenda Mann, et al. · Pharmacology & Therapeutics · 424
2015 · Margarethe Hofmann-Amtenbrink, David W. Grainger, et al. · Nanomedicine Nanotechnology Biology and Medicine · 229
2000 · Kristin B. McClary, Tatiana Ugarova, et al. · Journal of Biomedical Materials Research · 221
2013 · Mark A. Munger, Przemyslaw Radwanski, et al. · Nanomedicine Nanotechnology Biology and Medicine · 212
2012 · Clinton F. Jones, Robert A. Campbell, et al. · ACS Nano · 207
2014 · Anna Astashkina, David W. Grainger · Advanced Drug Delivery Reviews · 195
2013 · David W Grainger · Nature Biotechnology · 186
2009 · David M. Higgins, Randall J. Basaraba, et al. · American Journal Of Pathology · 183
2014 · Valentin Romanov, S. Nikki Davidoff, et al. · The Analyst · 182
2001 · Yunhua Hu, David W. Grainger, et al. · Journal of Biomedical Materials Research · 173
2002 · Kornelis A. Poelstra, Nazir A. Barekzi, et al. · Journal of Biomedical Materials Research · 158
1996 · Yihan Liu, D. Fennell Evans, et al. · Langmuir · 156
1990 · David W. Grainger, Anke Reichert, et al. · Biochimica et Biophysica Acta (BBA) - Biomembranes · 155
2010 · Dolly J. Holt, Lisa M. Chamberlain, et al. · Biomaterials · 143
2007 · D GRAINGER · Cardiovascular Research · 142
2012 · Clinton F. Jones, Robert A. Campbell, et al. · Molecular Pharmaceutics · 138
Works count: 403
Citation count: 17,980
H-index: 67
I10-index: 222
Year
Topic
Type